New hope for tough leukemia: experimental drug CT0991 enters human testing
Disease control
Terminated
This early-stage study tests a new drug called CT0991 in about 24 adults with acute myeloid leukemia that has come back or not responded to standard treatment. The main goals are to check the drug's safety, find the right dose, and see if it can help control the disease. Particip…
Phase: PHASE1 • Sponsor: He Huang • Aim: Disease control
Last updated May 02, 2026 17:44 UTC